SEC Company Response from CALYPTE BIOMEDICAL CORP (CIK 0000899426) — May 18, 2005
CALYPTE BIOMEDICAL CORP (CIK 0000899426)
Date: May 18, 2005 · CIK: 0000899426 · Accession: 0001144204-05-016321
AI Filing Summary & Sentiment
File numbers found in text: 333-116491, 333-117439, 333-119646, 333-124344
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Paula Winner Barnett, Esq.
17967 Boris Drive, Encino, CA 91316
tel (818) 776-9881
fax (818) 743-7491
pwbarnett@sbcglobal.net
May 18, 2005
VIA FACSIMILE
Russell Mancuso, Branch Chief
Tom Jones, Examiner
Division of Corporate Finance
Securities and Exchange Commission
450 Fifth Street, NW
Washington, D.C. 20549-0306
Re: Calypte Biomedical Corporation
Amendment No. 3 to Form SB-2 on Form S-3
Filed April 27, 2005
File No. 333-124344 (the "Registration Statement")
Dear Messrs. Mancuso and Jones:
On behalf of Calypte Biomedical Corporation ("Calypte"), the following are
Calypte's responses to the corresponding numbered comments in the May 13, 2005
letter from the Securities and Exchange Commission (the "Commission"). Calypte
has filed an amended Registration Statement on the EDGAR system, entitled
Post-Effective Amendment No. 4 to Form SB-2 on Form S-3, File No. 333-119646
(the "Amended Registration Statement"), to conform the Amended Registration
Statement to the Commission's comments to the Registration Statement and to the
financial statements and other disclosures made in Calypte's Form 10-QSB for the
quarter ended March 31, 2005 filed with the Commission on May 16, 2005. A copy
of the Amended Registration Statement marked to show the changes made from the
Registration Statement has been sent by facsimile to your attention.
Commission Comment, General, No. 1
1. Please reconcile (1) your registration statement facing page which
identifies the filing as an amendment with (2) the Edgar tag you chose
to use which identifies your filing as a new registration statement. If
you are not registering additional securities, you should not file a
new registration statement. If your intention is solely to create a
single prospectus per Rule 429, you should file a post-effective
amendment to the latest registration statement that registered
securities that are the subject of the single prospectus. The filing
should comply with the last sentence of Rule 429(b).
<PAGE>
Messrs. Mancuso and Jones
May 18, 2005
Page 2
Calypte Response, General, No. 1
1. Calypte has revised the Amended Registration Statement facing page to
identify it as a post-effective amendment to Calypte's latest
registration statement, File No. 333-119646. The purpose of the Amended
Registration Statement is to create a single prospectus per Rule 429 to
cover the resale by certain selling security holders of shares of
Calypte's common stock (the "Common Stock"), the resale of which was
previously registered pursuant to Registration Statement Nos.
333-119646, 333-116491 and 333-117439. No new shares are included in
the Amended Registration Statement. The Amended Registration Statement
is being filed to update the financial statements and disclosures in
Registration Statement Nos. 333-119646, 333-116491 and 333-117439. The
selling security holders table has been updated so that the Amended
Registration Statement includes only shares that have not previously
been sold. The Amended Registration Statement has been filed on the
EDGAR system as a post-effective amendment.
Commission Comment, General, No. 2
2. Please submit as correspondence on EDGAR your May 2, 2005, May 3, 2005
and May 8, 2005 letters.
Calypte Response, General, No. 2
2. Calypte has filed the requested letters on EDGAR.
Commission Comment, Prospectus Cover Page, No. 3
3. Please provide a one-page prospectus cover that is limited to required
information and information that is key to an investment decision. For
example, it is unclear why the previous registration status is relevant
to investors who are considering whether to purchase the securities
offered by the prospectus.
Calypte Response, Prospectus Cover Page, No. 3
3. The prospectus cover of the Amended Registration Statement has been
amended to cover only what Calypte believes is required information and
information that is key to an investment decision to purchase the
securities covered in the prospectus.
<PAGE>
Messrs. Mancuso and Jones
May 18, 2005
Page 3
Commission Comment, Exhibit 5.1, No. 4
4. The opinion that you file as an exhibit must be based on applicable law
and may not assume that that law is similar to some other jurisdiction.
We note that the opinion you filed impermissibly assumes that Delaware
law is the same as California law.
Calypte Response, Exhibit 5.1, No. 4
4. The legal opinion has been revised so that it is based on Delaware law.
The assumption that Delaware law is the same as California law has been
deleted.
Commission Comment, Exhibit 5.1, No. 5
5. Please ask your counsel to submit via Edgar a confirmation that it
concurs with our understanding that its reference "General Corporation
Law of the State of Delaware" includes the statutory provisions and all
applicable provisions of the Delaware Constitution and reported
judicial decisions interpreting these laws.
Calypte Response, Exhibit 5.1, No. 5
5. The legal opinion filed as Exhibit 5.1 has been revised to state that
the reference to the General Corporation Law of the State of Delaware
includes the statutory provisions and all applicable provisions of the
Delaware Constitution and reported judicial decisions interpreting
these laws.
Commission Comment, Exhibit 5.1, No. 6
6. Please tell us why the assumptions mentioned in the fourth paragraph
following paragraph (h) are necessary and appropriate for the shares
that are already outstanding.
Calypte Response, Exhibit 5.1, No. 6
6. Counsel has revised its legal opinion to delete the assumptions set
forth in the fourth paragraph following paragraph (h). The legal
opinion now states that the shares of Common Stock that are already
outstanding are legally issued, fully paid and nonassessable and that
the shares of Common Stock which are issuable upon exercise of the
warrants, conversion of the convertible debentures and in connection
with the consulting agreement registered under the Amended Registration
Statement when issued as described in the Description of Securities and
in accordance with the terms of each respective warrant, convertible
debenture and consulting agreement, and upon receipt by the Company of
the consideration provided for thereunder, will be legally issued,
fully paid and nonassessable.
<PAGE>
Messrs. Mancuso and Jones
May 18, 2005
Page 4
Calypte's officers and I are available to discuss with you any further comments
or questions you may have to assist your review of the Amended Registration
Statement in order for it to be effective at the earliest possible date.
Very truly yours,
/s/ Paula Winner Barnett
Paula Winner Barnett
cc: Mr. J. Richard George
</TEXT>
</DOCUMENT>